myopia
Conditions
Interventions
case group:0.01% atropine
control group:placebo
Sponsors
Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
7 Years to 12 Years
Inclusion criteria
Inclusion criteria: Aged 7-12 years old; cycloplegic SE: -6.0D to -2.0D; myopia progresses fast(=0.5D last year); distance corrected visual acuity: greater than or equal to 1.0; astigmatism:less than 1.5D; anisometropia: less than 1.0D; normal ocular pressure; without significantly strabismus or other eye diseases; no systemic diseases which may affecting visual development, such as diabetes; without the use of asthma drugs during the last year; having signed the informed consent.
Exclusion criteria
Exclusion criteria: Those who can't tolerate eye examinations; those with contraindication to atroppine; those with eyes visual function defects or stereo visual defects; those with the applying history of atropine or pirenzepine; those who are unable to voluntarily participate in this study; those who are allergic to atropie, cyclopentanone, proxymetacaine or benzalkonium chloride.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| myopia development;development of axial length; | — |
Countries
China
Contacts
Public ContactWang Ningli
Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University
Outcome results
None listed